The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB). Please read the press release
2021 Pipeline Report Tuberculosis Vaccines
From 20-22 April 2021 the virtual Global Forum on Tuberculosis (TB) Vaccines took place. Please read the meeting report.
We are delighted to announce that TBVI will once again organize its annual meeting in the Swiss mountains of Les Diablerets from 18-20 January 2022. We are currently compiling the program and [...]
Zendal and IAVI announce to partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials. For more information, please read the Press Release
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
